RecruitingNot ApplicableNCT02795052

Neurologic Stem Cell Treatment Study

Neurologic Bone Marrow Derived Stem Cell Treatment Study


Sponsor

MD Stem Cells

Enrollment

500 participants

Start Date

Jun 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will provide improvement in neurologic function for patients with certain neurologic conditions. http://mdstemcells.com/nest/


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether stem cells taken from a patient's own bone marrow (BMSCs) can help improve function in people with lasting damage to the nervous system — such as after a spinal cord injury, stroke, or neurological disease — that has not responded to standard treatments. **You may be eligible if...** - You are 18 years or older - You have documented, lasting damage to your brain, spinal cord, or nerves that is unlikely to improve with current standard care - Your condition has been stable for at least 6 months - If you are on medication or have had surgery for your condition, you are stable and not expected to recover function from that treatment alone - Your doctor believes you could potentially benefit from stem cell treatment and are at minimal risk - You are in good enough general health to undergo the procedure **You may NOT be eligible if...** - You are not medically stable - Your doctor does not consider you a suitable candidate for stem cell treatment - Your condition has been present for less than 6 months Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREIntravenous and Intranasal BMSC

Autologous Bone Marrow Derived Stem Cells provided intravenous and intranasal (lower 1/3 of nose)


Locations(3)

MD Stem Cells

Westport, Connecticut, United States

MD Stem Cells

Coral Springs, Florida, United States

The Saudi-German Hospital

Dubai, United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02795052


Related Trials